Why This National Pharmacy Commission Bill Matters
The Pharmacy Act, 1948, has governed pharmacy education and practice in India for nearly eight decades. Since then, the profession has expanded well beyond dispensing medicines at a retail counter. Pharmacists today work in clinical pharmacy, hospital pharmacy, pharmacovigilance, medical affairs, regulatory affairs, and pharmaceutical manufacturing, both in India and across global healthcare systems.
The existing council-based regulatory structure was not designed with this scale of specialisation in mind, and stakeholders have long called for reform.
The revised Bill responds to that gap. It proposes replacing the Pharmacy Council of India with a Commission-led governance model, separating education, quality assurance, ethics, and registration into specialised bodies, similar in spirit to reforms already introduced in medical education regulation.
Dr. Akram Ahmad (D.Pharm, B.Pharm, Pharm.D, and Ph.D from the University of Sydney and founder of Academically Global) has been closely tracking this development. "This is not just another policy update," he says. "It has the potential to reshape the future of pharmacy education, pharmacy regulation, and the pharmacy profession in India." According to Dr. Ahmad, the timing of this Bill matters because the profession itself has already moved on from where the Pharmacy Act, 1948 left off. "Today, pharmacists are no longer limited to traditional roles. They are contributing significantly across clinical pharmacy, hospital pharmacy, the pharmaceutical industry, drug safety, medical affairs, regulatory affairs, and global healthcare systems," he notes. "This Bill could define how future pharmacists are trained, assessed, and empowered." He raises four questions he believes every stakeholder should sit with before the consultation window closes:
- How will this impact pharmacy education standards?
- What changes can pharmacists expect in professional regulation?
- How will this affect career opportunities in India and globally?
- Will this improve the quality and future-readiness of pharmacy graduates?
His advice to students, educators, and industry professionals is simple. Read the draft carefully, understand its implications, and submit your honest feedback and suggestions before 31 July 2026. "This is your profession. Your voice matters. The future of Indian pharmacy will be shaped by the decisions we make today."
What the Draft Bill Proposes
Establishment of the National Pharmacy Commission (NPC): The Bill sets up the NPC as the apex statutory regulator for pharmacy education and practice, headquartered in New Delhi, with a Chairperson and a mix of ex-officio and part-time members drawn from academia, the profession, and government.
Three specialised boards. Instead of one council performing every regulatory function, the Bill proposes three boards under the Commission's oversight:
- The Pharmacy Education Board, responsible for setting curriculum standards and approving new institutions and courses.
- The Pharmacy Assessment and Rating Board, tasked with periodic institutional assessment, public ratings, and risk-based regulatory action instead of one-time approvals.
- The Pharmacy Ethics and Registration Board, which will maintain the National Register, process registration applications, and regulate professional conduct.
National Exit Test (Pharmacy): A central proposal is a common competency-based exit examination that pharmacy graduates, including those with recognised foreign qualifications, must clear before entering professional practice in India. This mirrors the National Exit Test model already used in medical education and is intended to standardise the quality of graduates entering the workforce, regardless of which institution they studied at.
Live National Register of Pharmacy Professionals: The Bill proposes a digitally synchronised register connecting State-level records with a national database in real time. This is expected to improve transparency, make it easier to verify a pharmacist's credentials, and support workforce mobility across states and, eventually, across borders.
Pharmacy Advisory Council: A formal mechanism is proposed for States and Union Territories to participate in shaping national pharmacy policy, addressing a long-standing gap in Centre-State coordination on health workforce regulation.
Quality assurance over one-time approval: Perhaps the most significant structural shift is the move away from a single approval granted once at the time an institution is set up. The new framework favours ongoing accreditation, periodic reassessment, publicly visible institutional ratings, and graded regulatory interventions for institutions that fall short of standards.
What This Means for Pharmacy Students and Professionals
For students, the National Exit Test could become the single most important checkpoint in their career, replacing a patchwork of state-level variation with one national standard. This has implications for how coaching, exam preparation, and career counselling services are structured going forward, much as it has for medical graduates preparing for national-level licensure exams.
For working pharmacists, a live national register could simplify verification when applying for jobs, hospital privileges, or overseas registration processes, since employers and regulators abroad increasingly expect digitally verifiable credentials.
For institutions, periodic reassessment and public ratings raise the stakes on maintaining quality year after year, rather than treating approval as a one-time milestone.
Global Mobility and Career Impact for Pharmacists and Graduates
If you are a healthcare professional looking for international registration pathways, such as pharmacists preparing for the OPRA exam in Australia, PEBC exam in Canada, DHA in Dubai or similar assessments elsewhere, a nationally standardised licensing framework at home could strengthen how Indian pharmacy qualifications are perceived and verified abroad.
A live, digitally synchronised register is particularly relevant here, since many overseas regulators already ask applicants to prove registration status through verifiable, real-time sources rather than paper certificates alone.
Pharmacy is no longer a profession limited by geography. After obtaining the required licensure, Indian pharmacists can build rewarding careers across countries such as Australia, Canada, the United States, New Zealand, and the Gulf, where demand continues to be driven by workforce shortages and expanding healthcare systems. Along with excellent career progression, these destinations also offer significantly higher earning potential than India.
Country | Average Annual Pharmacist Salary (2026) | Approx. Equivalent (₹) | Tax Benefits |
| Australia | AUD 95,000–110,000 | ₹53–61 lakh | Income tax applicable |
| Canada | CAD 100,000–120,000 | ₹63–76 lakh | Income tax applicable |
| United States | USD 125,000–145,000 | ₹1.06–1.23 crore | Federal & state taxes applicable |
| New Zealand | NZD 95,000–120,000 | ₹48–61 lakh | Income tax applicable |
| UAE | AED 120,000–180,000 | ₹28–42 lakh | No personal income tax |
| Qatar | QAR 180,000–300,000 | ₹42–70 lakh | No personal income tax |
| Saudi Arabia | SAR 120,000–180,000 | ₹27–40 lakh | No personal income tax |
| Kuwait | KWD 12,000–18,000 | ₹34–51 lakh | No personal income tax |
Note: Salaries vary depending on registration status, years of experience, employer (community, hospital, industry), location, and additional certifications. Many employers in Gulf countries also provide benefits such as accommodation, annual airfare, medical insurance, and relocation support, making the effective take-home package even more attractive.
A more robust national registration and exit-testing framework at home could make the documentation and verification process smoother for professionals pursuing such opportunities.
How to Submit Your Comments for the National Pharmacy Commission Bill 2026?
We definitely encourage every healthcare professionals to take part and voice out your opinions:
- Download and read the full draft Bill from the Ministry of Health and Family Welfare's website, under the News and Highlights section.
- Prepare clear, specific feedback, whether on the composition of the Commission, the design of the National Exit Test, the registration process, or the assessment framework for institutions.
- Email comments to the Under Secretary (AHS) at the Ministry, with the subject line "Comments/Suggestions on the National Pharmacy Commission Bill, 2026," or send them by post to the Ministry's New Delhi office.
- Ensure submissions reach the Ministry on or before 31 July 2026.
To Conclude with...
The revised Draft National Pharmacy Commission Bill, 2026, marks a significant step toward modernising how pharmacy education and practice are regulated in India. With a public comment window open until 31 July 2026, pharmacy students, working professionals, academic institutions, and industry bodies have a limited but meaningful opportunity to influence how this framework is finalised before it reaches Parliament. Given how directly the Bill's provisions, from the National Exit Test to the live national register, will shape training standards and career pathways for years to come, stakeholder participation now is likely to matter more than reactions after the law is passed.
